Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioMarket CapitalizationNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Assets: 2018-2024

Historic Return on Assets for Solid Biosciences (SLDB) over the last 6 years, with Sep 2024 value amounting to -0.47%.

  • Solid Biosciences' Return on Assets rose 10.00% to -0.47% in Q3 2024 from the same period last year, while for Sep 2024 it was -0.47%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.46% for FY2023, which is 4.00% down from last year.
  • Solid Biosciences' Return on Assets amounted to -0.47% in Q3 2024, which was down 22.15% from -0.38% recorded in Q2 2024.
  • In the past 5 years, Solid Biosciences' Return on Assets registered a high of -0.38% during Q2 2024, and its lowest value of -2.01% during Q3 2020.
  • Moreover, its 3-year median value for Return on Assets was -0.45% (2022), whereas its average is -0.47%.
  • Examining YoY changes over the last 5 years, Solid Biosciences' Return on Assets showed a top increase of 17bps in 2020 and a maximum decrease of 106bps in 2020.
  • Over the past 4 years, Solid Biosciences' Return on Assets (Quarterly) stood at -0.83% in 2020, then reached -0.45% in 2022, then fell by 11bps to -0.56% in 2023, then climbed by 10bps to -0.47% in 2024.
  • Its Return on Assets stands at -0.47% for Q3 2024, versus -0.38% for Q2 2024 and -0.44% for Q1 2024.